IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mittag, T. W.
Right arrow Articles by Ortega, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mittag, T. W.
Right arrow Articles by Ortega, M.

Investigative Ophthalmology & Visual Science, Vol 34, 2041-2048, Copyright © 1993 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Calmodulin activated adenylyl cyclase in ciliary processes: additivity of calcium and cyclic adenosine monophosphate signals on intraocular pressure response of the rabbit eye

TW Mittag, A Tormay, T Taniguchi and M Ortega
Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY 10029.

PURPOSE. The regulation of adenylyl cyclase by multiple signal systems was investigated by biochemical studies of the enzyme in ciliary processes and by in vivo intraocular pressure responses in the rabbit eye. METHODS. Adenylyl cyclase enzyme activity was determined by radiometric assay using alpha-32 P-ATP as substrate. Drugs were administered to the rabbit eye by intravitreal injection or topical application, and intraocular pressure was measured by pneumatonography. RESULTS. Adenylyl cyclase activity in the membrane/particulate fraction of the rabbit ciliary process was activated by calmodulin in the presence of Ca2+, Co2+, or Mn2+, and inhibited by the calmodulin antagonist calmidazolium. The activity was additive to stimulations of adenylyl cyclase by the activating G-protein (Gs) via isoproterenol or vasoactive intestinal peptide receptors, and by forskolin. The biochemical findings were supported by in vivo correlation experiments with intravitreal injection of MnCl2, and by topical treatment with the Ca(2+)-mobilizing alpha 1-adrenergic agonist phenylephrine and with agents affecting cyclic adenosine monophosphate levels (forskolin, isobutylmethylxanthine). The intraocular pressure response was augmented by combining threshold doses of phenylephrine with threshold doses of either forskolin or isobutylmethylxanthine. The maximal and most prolonged response (a decrease in intraocular pressure of 4 mm Hg for up to 8 hr) was obtained by combination treatment with all three agents at doses that produced no significant effect by themselves. CONCLUSIONS. These findings provide a biochemical mechanism for ocular hypotensive drugs having both a Ca(2+)-mobilizing activity as well as increasing cyclic adenosine monophosphate levels by receptor-coupled stimulation of adenylyl cyclase.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Association for Research in Vision and Ophthalmology